Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 220, pseudogene (RN7SL220P)

Target
RN7SL220P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, 7SL, cytoplasmic 220, pseudogene (RN7SL220P) is classified as a **pseudogene** derived from the 7SL RNA gene family, which encodes the RNA core of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting newly synthesized proteins to the endoplasmic reticulum[6][2][3][1][5]. As a pseudogene, RN7SL220P is a genomic locus that resembles the functional 7SL RNA gene but harbors mutations or structural changes that render it non-functional in classical SRP assembly and protein targeting. While some pseudogenes can be transcribed and potentially play *regulatory roles* (such as acting as microRNA decoys or sources of non-coding RNAs that modulate parental gene expression), there is currently no specific evidence that RN7SL220P itself has direct biological function or disease association. It is not a recognized therapeutic target, receptor, enzyme, transporter, or transcription factor. Its presence largely reflects the high evolutionary mobility and duplication history of the 7SL RNA family in the genome, which is also the source of human Alu repeats[1][5]. Pseudogenes like RN7SL220P are primarily used as markers in evolutionary and functional genomics research and are not directly targeted by drugs or therapeutics[6][2][4].

Other names
RN7SL220P7SL RNA pseudogeneRNA, 7SL, cytoplasmic 220, pseudogene
02

Biological functions

Possible regulator of gene expression via non-coding RNA mechanisms (such as miRNA sponge activity)genetic element with no known direct protein-coding function
03

Disease associations

Other (pseudogene-derived ncRNAs can be involved in gene regulation, but no direct evidence for this specific pseudogene in disease)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 220, pseudogene (RN7SL220P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 220, pseudogene (RN7SL220P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call